Rebus Holdings, Inc. (RBSH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Apr 14, 2026
Rebus Holdings Market Cap
Rebus Holdings has a market cap or net worth of $32 as of April 15, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
32.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since November 2, 2009, Rebus Holdings's market cap has decreased from 30.37M to 32.00, a decrease of -100.00%. That is a compound annual growth rate of -56.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 32.00 | - |
| Dec 31, 2024 | 32.00 | -99.98% |
| Dec 29, 2023 | 162.27K | -32.67% |
| Dec 30, 2022 | 241.00K | -12.12% |
| Dec 31, 2021 | 274.23K | -69.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baudax Bio | 5.25K |
| MultiCell Technologies | 5.00K |
| TetraLogic Pharmaceuticals | 4.86K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Xeno Transplants | 4.04K |
| MetaStat | 3.53K |
| Entia Biosciences | 3.41K |